ALHC insider buying & filings

← All candidates

ALHCAlignment Healthcare, Inc.

NasdaqGS · Healthcare · $1.81B

$8.71

-16.01% · Sep 16

One insider buy in the last year — $197.6K in all.
Nothing in the last fortnight.

Last Form 4 Sep 16 · scanned 13m ago

Price · 1Y · daily● 1 buy● 47 sells◆ 3 8-K

▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

▸ Included with Pro →

Market cap

$1.81B

Float

188.5M

91% public

Short % float

Pro

Price / profit

54.4

Price / future profit

11.6

Price / sales

0.4

The buyers

▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions

President - MSO

Kent Mark D.

Bought $197.6K on Jun 2 — 14,848 sh @ $13.31, held direct, 100% of their stake.

First Form 4 on file

no positions we can measure against the market — the record starts here

Institutional stakes

▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing

26 filingsnewest first

13GInvesco Ltd.5.0%Aug 13

13G/AGeneral Atlantic, L.p.0.1%May 15

13G/AWellington Management Group LLP8.4%May 15

13G/ABlackRock, Inc.6.7%Apr 24

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Sep 16SELLKao John E10b5-1Chief Executive Officerindirect27,400 @ $13.00$356.2K

Sep 11SELLMaroney Dawn ChristinePresidentdirect122,707 @ $12.68$1.56M

Sep 11SELLKao John E10b5-1Chief Executive Officerdirect385,270 @ $12.68$4.89M

Sep 11SELLKao John E10b5-1Chief Executive Officerindirect172,600 @ $12.96$2.24M

Aug 10SELLKao John E10b5-1Chief Executive Officerindirect298,000 @ $13.88$4.14M

77 more transactions on Pro →

Context

Wall St

$24.92 avg target

+186.1% vs today · 13 analysts · consensus Strong Buy

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

Earnings · EPS vs forecast

4 of 4 quarters beat

Q1 '26$0.12 act+$0.03

Q4 '25−$0.00 act+$0.08

Q3 '25$0.10 act+$0.11

Q2 '25$0.14 act+$0.13

Coverage

Alignment Healthcare (ALHC) Announces Executive Leadership Updates as John Kao Assumes Role of ChairmanInsider Monkey · 06-03 Down 25.5% in 4 Weeks, Here's Why Alignment Healthcare (ALHC) Looks Ripe for a TurnaroundZacks · 06-03 A Look At Alignment Healthcare (ALHC) Valuation After Analyst Downgrades And A Sharp 30-Day Share Price SlideSimply Wall St. · 06-03 Here's Why Alignment Healthcare (ALHC) is Poised for a Turnaround After Losing 31.0% in 4 WeeksZacks · 06-02

The file stays open

87 filings on record.
The next one will be too.

All candidates

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice

Kent Mark D.

87 filings on record.The next one will be too.

87 filings on record.
The next one will be too.